This is a historical report — it no longer reflects this drug's current status. Current status: Permanently Discontinued. View this drug's full profile page →
APO-LORAZEPAM
APOTEX INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is APO-LORAZEPAM discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that APO-LORAZEPAM 0.5MG has been permanently discontinued (last updated December 28, 2018). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is APO-LORAZEPAM not available?
The reason the manufacturer reported: Business reasons.
What this means
Does this mean the shortage is completely over everywhere?
It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.
What should I do?
If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.
DIN
00655740
Strength
0.5MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
LORAZEPAM
Tier
Unrated
Last Updated
2026-08-27
Reason for Shortage
Disruption of the manufacture of the drug.
Past Reports for This Drug
APO-LORAZEPAM has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from APOTEX INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
50MCG · DIN 02460513
325MG · DIN 02362341
500MG · DIN 02362368
DIN 02290901
325MG · DIN 02362422
500MG · DIN 02362244
10MG · DIN 02240414
20MG · DIN 02296098
150MG · DIN 02296160
75MG · DIN 02230507
2MG · DIN 02554194
2MG · DIN 02554178